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Background: Recent animal studies have identified that dietary salt intake may modify 
the risk and progression of autoimmune disorders through modulation of the IL-23/
TH17 pathway, which is critical in the pathogenesis of ulcerative colitis (UC) and Crohn’s 
disease (CD).
Methods: We conducted a prospective study of U.S. women enrolled in the Nurses’ 
Health Study (NHS) and NHSII who provided detailed and validated information on 
diet and lifestyle beginning in 1984 in NHS and 1991 in NHSII. We confirmed incident 
cases of UC and CD reported through 2010 in NHS and 2011 in NHSII. We used Cox 
proportional hazards models to calculate hazard ratios and 95% confidence intervals. In 
a case–control study nested within these cohorts, we evaluated the interaction between 
single nucleotide polymorphisms (SNPs) in genes involved in TH17 pathway and dietary 
potassium on risk of CD and UC. In a cohort of healthy volunteers, we also assessed 
the effect of supplemental potassium on development of naïve and memory T cells, 
differentiated with TGFβ1 or TH17 conditions.
results: Among a total of 194,711 women over a follow-up of 3,220,247 person-years, 
we documented 273 cases of CD and 335 cases of UC. Dietary intake of potassium 
(Ptrend = 0.005) but not sodium (Ptrend = 0.44) was inversely associated with risk of CD. 
Although, both dietary potassium and sodium were not significantly associated with 
risk of UC, there was a suggestion of an inverse association with dietary potassium 
(Ptrend = 0.08). The association of potassium with risk of CD and UC appeared to be 
modified by loci involved in the TH17 pathway that have previously been associated 
with susceptibility to CD, particularly SNP rs7657746 (IL21) (Pinteraction = 0.004 and 0.01, 
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respectively). In vitro, potassium enhanced the expression of Foxp3 in both naïve and 
memory CD4+ T cells via activating Smad2/3 and inhibiting Smad7 in TH17 cells.
conclusion: Dietary potassium is inversely associated with risk of CD with both in vitro 
and gene–environment interaction data suggesting a potential role for potassium in 
regulating immune tolerance through its effect on Tregs and TH17 pathway.
Keywords: inflammatory bowel disease, crohn’s disease, ulcerative colitis, dietary potassium, immune tolerance, 
Th17 pathway, nurses’ health study
inTrODUcTiOn
Inflammation bowel disease (IBD), comprised of Crohn’s dis-
ease (CD) and ulcerative colitis (UC), is a chronic inflammatory 
disorder of the gastrointestinal tract. Through identification 
of over 160 risk loci (1–3), genome-wide association (GWA) 
studies have identified a number of key pathways involved in 
the development of CD and UC, including the IL-23/TH17 
axis, autophagy, and mucosal barrier function. However, it 
is estimated that the risk attributable to genetic predisposi-
tion alone is less than 25% (4), highlighting the importance 
of identifying environmental factors associated with IBD 
susceptibility. In addition, understanding the interrelationship 
between genetic markers and environmental factors, also known 
as gene– environment interaction, can provide insight into the 
etiopathogenesis of IBD.
Recently, animal studies have shown a role for dietary sodium 
in the development and progression of autoimmune disorders 
through inducing IL-23-IL-23R-mediated induction of patho-
genic TH17 cells, which plays a critical role in development of 
IBD (5–7). In addition, sodium appears to not only enhance the 
induction of TH17 cells but also inhibit the suppressive functions 
of Foxp3+ Treg cells (8). Sodium may also lead to macrophage 
activation creating a more inflammatory environment (9). High 
salt levels inhibit alternative activation of macrophages (M2) 
resulting in attenuation of tissue inflammation (10). Similarly, 
sodium impairs Treg function by inducing IFNγ produc-
tion in these cells. Taken together, these data point to a high 
sodium diet leading to an enhanced proinflammatory response 
through interference with both innate and adaptive regulatory 
mechanisms.
To date, there are limited data on the direct effect of potas-
sium on effector and regulatory T cells. Nevertheless, human 
and animal data have also supported a link between potassium 
channels expressed in the intestinal epithelial cells and risk 
of development of CD or intestinal inflammation in animal 
models of colitis (11, 12). We therefore sought to prospectively 
examine the association between dietary intake of sodium and 
potassium and risk of incident CD and UC within the large, well-
characterized Nurses’ Health Study (NHS) and NHSII cohorts. 
In addition, we aimed to better characterize these associations by 
examining gene–environment interactions using susceptibility 
loci previously identified through GWA studies with risk of CD 
and UC. Finally, we confirmed the functional significance of our 
findings through in  vitro studies examining the effect of these 
minerals on regulatory and effector T cells.
MaTerials anD MeThODs
cohort study: Dietary sodium and 
Potassium and risk of Uc and cD
Study Population
The NHS is a prospective cohort study comprised of nearly 
121,700 U.S. women, ages 30–55 years, who completed a mailed 
health questionnaire starting in 1976. Information on health 
information has since been updated every 2  years through 
follow-up questionnaires. NHSII is a similar cohort of 116,686 
U.S. women between the ages of 25–42 years that was started in 
1989. These women have been followed with similar biennial 
questionnaires. The Human Research Committee at Partners 
Healthcare approved this study.
Assessment of Diet
Dietary assessment was performed using a 161-item semi-
quantitative food frequency questionnaire (SFFQ) starting 
in 1984 in NHS and updated in 1986 and every 4 years since. 
Similarly in NHSII, dietary intake was assessed using SFFQ 
staring in 1991 and updated every 4 years. We calculated nutri-
ent intake from the number of servings of food items and U.S. 
Department of Agriculture data on the content of nutrients in 
specified portions. The reproducibility and validity (against 
dietary records) of the FFQs have been extensively documented 
(13, 14). All nutrient values were adjusted for total caloric intake 
by the residual method to estimate intakes independent of the 
amount of total intake. The correlation between energy-adjusted 
potassium obtained from FFQ and diet records was 0.53 (15). 
In addition, the correlation between dietary potassium obtained 
from FFQ and urinary secretion of potassium was 0.56 in men 
and 0.39 in women and that of sodium was 0.66 in men and 0.56 
in women (16). For questionnaire cycles with no assessment of 
dietary intake, we carried forward data from the prior question-
naire cycle when this detailed assessment was done. However, we 
did not carry forward dietary information. Specifically, women 
with missing dietary data in a 2-year cycle when dietary data 
was specifically queried did not contribute person-year to the 
analyses.
Assessment of Other Covariates
Detailed information on lifestyle factors, including body weight, 
smoking status, use of non-steroidal anti-inflammatory drugs 
(NSAIDs), menopausal hormone therapy, and oral contracep-
tives were collected and updated in each questionnaire cycle. 
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Information on physical activity was also estimated using an 
instrument administered every 2–4 years that has been described 
in detail (17). Participants’ self-report of body weight, height, 
physical activity, and use of oral contraceptives have been previ-
ously validated (18–20). In 1992, in NHS and 1991 in NHSII, 
women were also asked about their latitude of residence at age 
30, which we have previously shown to be associated with risk 
of UC and CD (21). Information about history of appendectomy 
was collected in 1992 in NHS and 1995 in NHSII.
Information on ancestry was collected in the 1992 question-
naire in NHS and baseline questionnaire in NHSII. Specifically, 
women were asked whether they had the following ancestries: 
African, Asian, Hispanic, Scandinavian, southern European/
Mediterranean, other white, or other ancestry. Most of women 
(93% in the NHS I, 91% in the NHSII) reported white ancestries, 
consistent with underrepresentation of minorities in healthcare 
at the inception of both cohorts. More than 90% of the women 
reported a single ancestry. Ancestry data were available in more 
than 95% of women in NHS and 99% of women in NHSII.
Outcome Ascertainment
Detailed information on confirmation of self-reported cases of 
CD and UC has been previously reported (17, 21, 22). Briefly, 
since 1976, participants have reported diagnoses of UC or CD 
through an open-ended response on biennial surveys. Diagnoses 
of UC and CD have also been specifically queried since 1982 
and 1992, respectively. Similarly in NHSII, both diagnoses were 
specifically queried starting in 1993. Participants who reported 
diagnosis of CD or UC on any biennial questionnaire received 
a supplementary questionnaire. In addition, medical records 
from these participants were requested and reviewed by two 
gastroenterologists blinded to exposure information. We used 
standardized criteria to confirm cases of CD and UC (23–26).
Statistical Analysis
For analysis of dietary sodium, potassium, and food items, 
person-time for each participant was calculated from the date 
of return of their baseline questionnaires to the date of the 
diagnosis of UC or CD, date of last returned questionnaire, or 
June 1, 2010 for NHS and June 1, 2011 for NHSII, whichever 
came first. At baseline, we excluded participants with missing 
dietary data and history of IBD or cancer (with the excep-
tion of non-melanoma skin). We calculated adjusted hazard 
ratios (HRs) and 95% confidence intervals (CIs) using Cox 
proportional hazards modeling incorporating time-varying 
covariates. Consistent with prior analyses, information on BMI 
was derived from baseline questionnaire to avoid potential bias 
from changes in weight by preclinical disease (27, 28). Dietary 
sodium and potassium were modeled as quintiles while food 
items were modeled based on number of servings consistent 
with prior dietary analysis (28, 29). We observed no heterogene-
ity in the association of dietary sodium, potassium, and food 
items with CD or UC in separate analyses of NHS and NHSII 
(P for heterogeneity >  0.50 for both UC and CD). Thus, we 
pooled individual-level data from NHS and NHSII and adjusted 
for cohort in all analyses. We used the first quintile as the refer-
ence category and calculated the risk of CD and UC for each 
quintile of dietary sodium and potassium by comparing higher 
quintiles to the first quintile. Using previously described meth-
ods, we performed mediation analysis to determine whether the 
reported association of fiber intake on risk of CD was explained 
by intake of potassium (30). We used SAS version 9.3 (Cary, NC, 
USA) for all analyses.
nested case–control study: Dietary 
Potassium, Th17 Pathway and risk of  
cD and Uc
Study Population
In 1989–1990, 32,826 NHS participants (aged 43–69  years) 
returned a blood sample on ice packs by overnight courier and 
completed a short questionnaire (31). Between 1996 and 1999, 
29,611 NHSII participants (aged 32–54 years) provided blood 
samples and completed a short questionnaire in a similar pro-
tocol (32). Similarly in 2001–2004, 29,684 participants in NHS 
and 29,859 participants in NHSII mailed in a sample of buccal 
cells collected using a “swish-and-spit” method. Participants 
who provided the buccal cells had not previously provided a 
blood specimen. Among participants who provided a blood or 
saliva specimen, we matched 169 CD cases to 740 controls and 
202 UC cases to 740 controls based on age, menopausal status, 
month of blood collection, and fasting status. Genomic DNA 
was isolated from buccal cells or blood samples using conven-
tional methods (33).
Genotyping and Computation of Risk Score
We used the most recent meta-analysis of GWA studies to identify 
six single nucleotide polymorphisms (SNPs) in genes involved in 
TH17 pathway that have previously been associated with risk of 
CD and UC: rs10758669 (JAK2), rs12942547 (STAT3), rs1819333 
(CCR6), rs7657746 (IL21), rs3024505 (IL10), and rs11209026 
(IL23R) (3). We directly genotyped these SNPs by 5′ nuclease 
assay (TaqMan®), using the ABI PRISM 7900HT Sequence 
Detection System (Applied Biosystems, Foster City, CA, USA). 
TaqMan® primers and probes were designed using the Primer 
Express® Oligo Design software v2.0 (ABI PRISM). The status of 
individual case–control status was not known to laboratory per-
sonnel. Genotyping procedures were validated using duplicates 
from nearly 10% of the samples; concordance was 100% for these 
samples. Primers, probes, and conditions for the genotyping assay 
are available upon request. We confirmed that all SNPs were in 
Hardy–Weinberg equilibrium among the controls using the Chi-
square test (all P > 0.30).
We examined associations according to each of the TH17 
pathway SNPs except rs11209026 (IL23R) due to low minor allele 
frequency (~7%). However, we also constructed two summary 
risk scores (one for each outcome) incorporating all six TH17 
pathway SNPs associated with CD and UC risk using a previ-
ously described weighting method (34, 35). Briefly, each SNP was 
recoded as 0, 1, or 2 according to the number of alleles associated 
with increasing risk of CD or UC; each SNP was weighted by 
its relative effect size (β coefficient) derived from the previously 
reported meta-analysis data (separate β coefficient for UC and 
CD) (3). We constructed the genetic risk score using the equation: 
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genetic risk score =  (β1 ×  SNP1 +  β2 ×  SNP2 + … +  βn ×   
SNPn)/(sum of the β coefficients).
Statistical Analysis
We used conditional logistic regression for risk of CD or UC 
with a multiplicative interaction term for dietary potassium and 
genotype in TH17 pathways defined according to the number of 
risk alleles while adjusting for other potential risk factors (see 
Assessment of Other Covariates). Since CD and UC are rare 
outcomes, we used odds ratios as estimates of relative risks. To 
minimize the potential influence of reverse causality, we analyzed 
prospectively collected data on diet from the questionnaires 
administered 4 years prior to diagnosis of CD or UC for cases and 
their matched controls. Although, there were no significant vari-
ations in allele frequency of genotyped risk variants according to 
European ancestry, we adjusted all models of gene–environment 
interaction for ancestry (see Assessment of Other Covariates). 
We used SAS version 9.3 (Cary, NC, USA) for these analyses. All 
P-values were two-sided and <0.05 was considered statistically 
significant. As the selection of the SNPs was done a priori and 
interaction with only five SNPs was tested, we did not adjust for 
multiple testing in our analyses.
experimental In Vitro studies: effect of 
Potassium on Th17/Treg cell Balance
In Vitro Human T Cell Differentiation and Intracellular 
Staining
After obtaining consent, we collected 10 cc of peripheral blood 
from 25 healthy volunteers, ages 18–35 years without history of 
HIV, tuberculosis, or any autoimmune diseases (e.g., rheumatoid 
arthritis, systemic lupus, etc.) and who were not taking steroids 
or other immunosuppressive medications. All experiments 
were performed in accordance to the approved guidelines of 
Human Ethics Committee of Translational Health Science and 
Technology Institute (THSTI), Faridabad, India.
Peripheral blood mononuclear cells (PBMCs) were isolated 
by Ficoll Paque density gradient centrifugation (GE Healthcare). 
Naïve CD4+ CD45RO−CD25− or memory CD4+CD45RO+ 
T cells were sorted as previously described (36). Sorted cells 
were cultured in 96-well U-bottom plates at a concentration of 
0.1 × 106 cells/ml in X-VIVO 15 medium (Lonza) supplemented 
with 100 units/ml Penicillin/Streptomycin, l-glutamine, NEAA, 
and Sodium Pyruvate. Cells were stimulated with plate bound 
anti-CD3 (UCHT1; 10 μg/ml), soluble anti-CD28 (28.2; 3.0 μg/
ml), and were differentiated either with TGFβ1 (1  ng/ml) or 
with TH17 condition with addition of following cocktails: TGFβ1 
(5.0 ng/ml; R&D), IL-6 (25 ng/ml; Peprotech), IL-1β (12.5 ng/ml; 
Peprotech), IL-21 (20  ng/ml; Peprotech), and IL-23 (20  ng/ml; 
Peprotech) for 6 days. Cells were supplemented with or without 
potassium chloride (Sigma Aldrich). On day 6, cells were stained 
with LIVE/DEAD Fixable Dead Cell Stain Kit (Invitrogen) 
according to manufacturer’s protocol. Cells were then fixed and 
permeabilized with BD Cytofix/Cytoperm and stained with anti-
human Foxp3-PE antibody (BD Bioscience; 560082). Labeled 
cells were acquired on BD FACS Verse and analyzed by FlowJo 
(Treestar, USA). All FACS plots were gated on live cells.
CFSE T Cell Proliferation Assay
For proliferation assay, sorted naïve human CD4+ T cells (1 × 106/
ml) were labeled with 5.0 μM of CFSE in PBS at 37°C for 5 min. 
Cells were shaken intermittently in order to get homogenously 
labeled cell population. Cells were thoroughly washed with 
glutamine rich media (RPMI-1640) to wash off unlabeled dye. 
Cells were stimulated with plate bound anti-CD3 and soluble 
anti-CD28 in round bottom 96-well plate at a concentration of 
0.1 × 106/ml with and without KCl (40mM). On day 5, cells were 
washed extensively with 1× PBS and fixed and permeabilized 
with Foxp3 staining kit (eBiosciences; 00-5523-00) and were 
labeled with fluorescent-conjugated Foxp3 antibody (Biolegend, 
320014) for 30–40 min on ice. Cells were also stained with live/
dead marker to exclude dead population during analysis. Prism 
5.0 was used for statistical analysis and differences were consid-
ered statistically significant with a P value of less than 0.05.
Taqman PCR and Gene Expression
RNA was isolated using RNAeasy mini kit [Qiagen (#74134)], 
and converted to cDNA using iScript cDNA synthesis kit [BioRad 
(#1708891)]. The Taqman primers used for this study were 
purchased from Applied Biosystems (Smad3 Hs00969210_m1, 
Smad2 Hs00183425_m1, Smad7 Hs00998193_m1, and SGK1 
Hs00985033_g1 Taqman primers). The values are represented 
as the difference in Ct values normalized to GAPDH for each 
sample.
Detection of Phosphorylated Smad Proteins
Peripheral blood mononuclear cells were isolated from healthy 
volunteers and naïve and memory CD4+ T cells were sorted as 
described previously. Cells were stimulated for 1  h with plate 
bound anti-CD3 and soluble anti-CD28. Thereafter, cells were 
washed extensively with ice cold 1× PBS and stained with live dead 
stain (Thermo fisher) for exclusion of any dead cell population 
during analysis. Cells were fixed with 2% paraformaldehyde at 
37°C for 20 min in order to cross link the phospho proteins. Cells 
were again washed twice with ice cold 1× PBS and permeabilized 
with 90% ice cold methanol at 4°C for 60 min. Cells were washed 
again and incubated with FACS buffer (PBS + 2% FCS) to prevent 
non-specific binding. Cells were stained with phospho Smad 
specific antibodies at 4°C for 40′ according to the manufacture’s 
recommendations. Finally, cells were stained with appropriate 
fluorescent-conjugated secondary antibodies, data were acquired 
by BD FACSVerse and analyzed by FlowJo. Following antibodies 
(phosphorylation sites included in parentheses) from Abcam 
were used: ab53100 (pSMAD2, pS467) and ab52903 (pSMAD3, 
pS423 + S425) for these experiments.
resUlTs
Dietary sodium and Potassium and risk 
of Uc and cD
Through 2011, we documented 273 cases of CD and 335 cases of 
UC among 194,711 women who contributed 3,220,247 person-
years of follow-up. Compared to women in the lower quintiles 
of dietary potassium intake, women in the highest quintile were 
TaBle 2 | Dietary sodium and potassium intake and risk of crohn’s disease and ulcerative colitis.
Q1 Q2 Q3 Q4 Q5 Ptrendb
Dietary potassium intake
crohn’s disease
Cases/person-years 68/637,956 65/646,862 55/647,848 41/647,065 44/640,516
Age-adjusted HR, 95% CI 1.00 0.94 (0.67–1.33) 0.79 (0.55–1.13) 0.59 (0.40–0.88) 0.63 (0.43–0.92) 0.002
MV-adjusted HR, 95% CIa 1.00 0.91 (0.64–1.29) 0.76 (0.52–1.11) 0.58 (0.38–0.88) 0.62 (0.40–0.95) 0.005
Ulcerative colitis
Cases/person-years 71/637,956 74/646,862 71/647,848 61/647,065 58/640,516
Age-adjusted HR, 95% CI 1.00 1.02 (0.74–1.42) 0.97 (0.69–1.34) 0.83 (0.59–1.17) 0.80 (0.56–1.13) 0.09
MV-adjusted HR, 95% CIa 1.00 1.00 (0.71–1.39) 0.94 (0.66–1.33) 0.79 (0.54–1.15) 0.74 (0.50–1.11) 0.08
Dietary sodium intake
crohn’s disease
Cases/person-years 53/638,430 54/645,396 54/645,264 37/646,930 75/644,226
Age-adjusted HR, 95% CI 1.00 1.01 (0.69–1.48) 1.01 (0.69–1.47) 0.69 (0.45–1.06) 1.41 (0.99–2.01) 0.25
MV-adjusted HR, 95% CIa 1.00 1.00 (0.68–1.46) 0.98 (0.67–1.44) 0.67 (0.44–1.02) 1.32 (0.92–1.89) 0.44
Ulcerative colitis
Cases/person-years 62/638,430 68/645,396 66/645,264 72/646,930 67/644,226
Age-adjusted HR, 95% CI 1.00 1.10 (0.78–1.56) 1.05 (0.74–1.48) 1.15 (0.82–1.61) 1.07 (0.75–1.51) 0.68
MV-adjusted HR, 95% CIa 1.00 1.08 (0.77–1.53) 1.03 (0.73–1.46) 1.12 (0.80–1.58) 1.04 (0.73–1.48) 0.77
CI, confidence interval; Q, quintiles.
aModels adjusted for age (months), smoking (never, past, current), body mass index at baseline (<20, 20–24.9, 25–29.9, ≥30 kg/m2), oral contraceptive use (ever, never), hormone 
therapy (never, past, current, premenopause), appendectomy (no, yes), geographic latitude of residence at age 30 (southern, middle, northern, missing/unknown), updated physical 
activity (quintiles), cohorts (NHS, NHSII), NSAID’s use (<2 tablets/week, ≥2 tablets/week), updated fiber intake (quintiles), and total caloric intake.
bPtrend was calculated by entering the median value for each quintile into the model as a continuous variable.
TaBle 1 | Baseline characteristics of participants according to quintiles of total dietary potassium intake.a
Q1 (N = 34,648) Q2 (N = 34,818) Q3 (N = 34,809) Q4 (N = 34,835) Q5 (N = 34,812)
Age (years), mean (SD) 42 (9) 42 (9) 43 (10) 44 (10) 45 (10)
Body mass index (kg/m2), mean (SD) 25 (6) 25 (5) 25 (5) 25 (5) 25 (5)
Smoking
Never 60 58 56 54 50
Past 21 25 27 29 31
Current 19 17 17 17 19
Latitude of residence, %
Southern latitude 14 14 14 15 16
Appendectomy, % 18 19 20 20 21
Premenopause, % 73 72 69 67 64
Menopausal hormone therapy, %b
Never 54 53 53 54 53
Past 20 21 21 21 21
Current 26 26 26 25 26
Ever use of oral contraceptives, % 70 69 68 67 65
Regular use of NSAIDs, % 12 12 11 12 13
Fiber intake (g/day), mean (SD) 14 (3) 16 (4) 17 (4) 19 (5) 22 (6)
Potassium intake (mg/day), mean (SD) 2,218 (655) 2,701 (703) 2,996 (754) 3,279 (824) 3,754 (1,059)
Sodium intake (mg/day), mean (SD) 1,916 (691) 2,055 (696) 2,091 (689) 2,098 (694) 2,079 (748)
aValues are means (SD) or percentages and are standardized to the age distribution of the study population. All variables are derived from baseline questionnaires (1984 in NHS and 
1991 in NHSII) with the exception of geographic location (1992 in NHS and 1993 in NHSII) and appendectomy (baseline in NHS and 1995 in NHSII).
bPercentages among postmenopausal women.
5
Khalili et al. Dietary Potassium and Risk of IBD
Frontiers in Immunology | www.frontiersin.org December 2016 | Volume 7 | Article 554
slightly older, more likely to live in a southern latitude, had a 
higher intake of daily fiber, and less likely to have never smoked 
(Table 1). There were no significant differences according to BMI, 
history of appendectomy, use of NSAIDs, oral contraceptives, or 
menopausal hormone therapy, and dietary sodium intake accord-
ing to quintiles of potassium intake.
Compared to women in the lowest quintile of dietary potas-
sium intake, the multivariable-adjusted HRs for CD were 0.91 
(95% CI, 0.64–1.29) for women in the second quintile, 0.77 (95% 
CI, 0.53–1.11) for the third quintile, 0.58 (95% CI, 0.38–0.88) for 
the fourth quintile, and 0.62 (95% CI, 0.40–0.95) for the highest 
quintile (Ptrend =  0.005) (Table  2). Similarly, dietary potassium 
was inversely associated with risk of UC, although the associa-
tion did not reach statistical significance (Ptrend = 0.08). We did 
not find an association between dietary sodium and risk of CD 
(Ptrend = 0.44) or UC (Ptrend = 0.77) (Table 2).
TaBle 3 | risk of crohn’s disease and ulcerative colitis according to dietary potassium intake in strata of snPs in Th17 Pathways.a
control (n = 740) crohn’s disease (n = 169) Ulcerative colitis (n = 202)
Entire cohort (NHS + NHSII) 1.00 0.93 (0.86–1.00) 0.98 (0.91–1.05)
rs7657746 (IL21) GG (n = 77) 1.00 1.58 (1.15–2.16) 1.12 (0.90–1.54)
AG (n = 382) 1.00 0.96 (0.86–1.07) 1.02 (0.93–1.12)
AA (n = 613) 1.00 0.90 (0.82–0.98) 0.90 (0.83–0.98)
Pinteractionb 0.004 0.01
rs10758669 (JAK2) AA (n = 491) 1.00 0.89 (0.81–0.98) 0.97 (0.89–1.06)
AC (n = 393) 1.00 0.98 (0.88–1.10) 0.97 (0.87–1.07)
CC (n = 177) 1.00 1.02 (0.86–1.21) 1.04 (0.90–1.19)
Pinteractionb 0.12 0.58
rs12942547 (STAT3) GG (n = 174) 1.00 0.93 (0.78–1.11) 0.97 (0.84–1.12)
AG (n = 393) 1.00 0.97 (0.87–1.08) 1.03 (0.93–1.14)
AA (n = 421) 1.00 0.92 (0.82–1.02) 0.93 (0.85–1.03)
Pinteractionb 0.48 0.42
rs1819333 (CCR6) GG (n = 246) 1.00  0.93 (0.80–1.07) 0.96 (0.86–1.08)
GT (n = 486) 1.00 0.91 (0.82–1.00) 0.93 (0.85–1.02)
TT (n = 364) 1.00 1.01 (0.91–1.12) 1.02 (0.92–1.13)
Pinteractionb 0.18 0.41
rs3024505 (IL10) GG (n = 773) 1.00 0.93 (0.86–1.00) 0.96 (0.89–1.03)
AG (n = 276) 1.00 1.03 (0.89–1.19) 1.06 (0.94–1.19)
AA (n = 30) 1.00 0.68 (0.34–1.36) 0.83 (0.62–1.12)
Pinteractionb 0.73 0.92
Bold values representing statistically significant P-value.
aOdds ratios are calculated for every 200 mg increase in dietary potassium intake.
bModels were adjusted for same variables as in Table 2 plus ethnicity.
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We explored the possibility that pre-diagnosis symptoms may 
have altered dietary intake and therefore could account for our 
observed inverse association between dietary potassium and risk 
of CD. Thus, we performed sensitivity analysis using dietary data 
derived at least 4 years prior to each 2-year follow-up cycle and 
observed similar associations. Compared to women in the lowest 
quintile of dietary potassium, the multivariable-adjusted HR of 
CD among women in the highest quintile of dietary potassium 
was 0.60 (95% CI, 0.37–0.95) (Ptrend = 0.002). Similarly, we did 
not find an association between dietary potassium and risk of 
UC (Ptrend = 0.54). Compared to women in the lowest quintile of 
dietary potassium, the MV-adjusted HR of UC among women in 
the highest quintile was 1.00 (95% CI, 0.65–1.53).
We examined the possibility that specific food items with the 
highest contribution to dietary potassium and not cumulative 
daily potassium intake may explain our observed association and 
therefore examined the independent effect of skim milk (~9% of 
daily potassium), potato (~6% of daily potassium), and orange 
juice (~3% daily potassium) on risk of CD and UC. We did not 
observe any inverse association between orange juice, skim milk, 
and potato and risk of CD (all Ptrend > 0.20). Similarly, we did not 
observe an association between food items with the highest con-
tribution to dietary potassium and risk of UC (all Ptrend > 0.50). 
In addition, we assessed the independent effect of supplements 
containing potassium such as multivitamins on risk of CD and 
UC and observed no associations (all Ptrend > 0.30).
As food items with high fiber content, particularly crucifer-
ous vegetables, also contain large amounts of potassium, we 
hypothesized that previous inverse associations reported between 
dietary fiber intake and risk of CD may be mediated by potassium 
(29). In a mediation analysis, we estimate that, dietary potassium 
intake appeared to contribute to nearly 90% (95% CI, −32 to 
210%) of the association of fiber intake on CD. Specifically, the 
risk of CD with each one-category increase in quintile category 
of fiber intake was 0.92 (95% CI, 0.85–1.00) before adjustment 
for potassium (hypothesized intermediate) and 0.99 (95% CI, 
0.89–1.10) after adjustment. However, a formal test of mediation 
did not reach statistical significance (P = 0.15).
interaction between Dietary Potassium 
and snPs in Th17 Pathway
We explored the possibility of gene–environment interaction 
between dietary potassium and the TH17 pathway on risk of 
CD and UC in our nested case–control study (Table 3). Similar 
to our primary analyses, dietary potassium appears to to be 
inversely associated with risk of CD but not UC. Specifically, 
each 200 mg increase in dietary of potassium was associated with 
a 7% reduction in risk of CD (OR = 0.93, 95% CI, 0.86–1.00). 
Although we did not observe a significant interaction between 
dietary potassium and specific SNPs in STAT3, JAK2, CCR6, and 
IL10 (all Pinteraction >  0.15), the association of dietary potassium 
with risk of CD appeared to be modified by rs7657746 (IL21) 
(Pinteraction = 0.004). Among participants with GG genotype, each 
200  mg increase in dietary potassium was associated with an 
increased risk of CD (OR = 1.58, 95% CI, 1.15–2.16). In contrast, 
each 200 mg increase in dietary potassium was associated with 
an OR for CD of 0.96 (95% CI, 0.86–1.07) among individuals 
with GA genotypes and 0.90 (95% CI, 0.82–0.98) among indi-
viduals with AA genotypes. We also constructed a genetic risk 
score comprised of the number of CD or UC susceptibility alleles 
associated with the TH17 pathway on risk of CD. An interaction 
between dietary potassium and this genetic risk score approached 
statistical significance (Pinteraction = 0.06). In addition, we observed 
FigUre 1 | effect of extracellular potassium on generation of Foxp3+ Treg cells. (a,B) Naïve (CD4+ CD45RO−CD25−) and memory (CD4+CD45RO+) CD4+ 
T cells were sorted and stimulated in vitro with anti-CD3 and anti-CD28 in presence of KCl (40mM) and CFSE, and Foxp3 expression was determined by 
intracellular staining and analyzed by flow cytometry after 6 days in vitro. (c) Naïve (CD4+ CD45RO−CD25−) and memory (CD4+CD45RO+) CD4+ T cells were sorted 
and stimulated in vitro with anti-CD3 and anti-CD28 in presence of TGF-β (2 ng/ml) with and without KCl (40mM), Foxp3 expression was determined by intracellular 
staining and analyzed by flow cytometry after 6 days in vitro. (D,e) Naïve (CD4+ CD45RO−CD25−) and memory (CD4+CD45RO+) CD4+ T cells were sorted and were 
stimulated in vitro with anti-CD3 and anti-CD28 in presence of TGF-β (2 ng/ml) and indicated doses of KCl, after 5–6 days, culture cells were analyzed for the 
intracellular levels of Foxp3 protein by flow cytometry. (F) Sorted naïve human CD4+ T cells were activated with anti-CD3 and anti-CD28, cells were polarized into 
TH17 conditions (TGF-β1 + IL-6 + IL-21 + IL-23 + IL-1β) in vitro either in normal media or media containing potassium (40mM), polarized TH17 cells were analyzed 
by flow cytometry after 6 days for percentage of Foxp3-expressing CD4+ T cells. Data are a cumulative plot of five individuals, each dot represents one individual 
(n = 5). Error bars SD **P < 0.01, ***P < 0.001 (Student’s t-test). (g) Naïve CD4+ T cells were activated with anti-CD3 and anti-CD28, cells were either polarized into 
TH17 culture condition (TGF-β1 + IL-6 + IL-21 + IL-23 + IL-1β) or TGF-β1 alone or without any cytokines (TH0) either in normal media or media containing potassium 
(40mM), cells were analyzed by flow cytometry for live/dead stain (Life technologies) by cell viability assay and represented as frequency of viable CD4+ T cells. Data 
are a cumulative plot of six to seven individuals. Each dot represents one individual. n.s., non-significant.
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a similar interaction between dietary potassium and rs7657746 
(IL21) on risk of UC (Pinteraction =  0.01). Particularly, similar to 
CD, among participants with CC genotype, each 200 mg increase 
in dietary potassium was associated with an OR for UC of 0.90 
(0.83–0.98).
effect of extracellular Potassium on 
generation of Foxp3+ Treg cells
Immune activation and tolerance in autoimmune diseases 
are mediated by the interactions between genes and environ-
ment. Experimental data suggest that higher physiologic salt 
concentration enhances the induction of proinflammatory 
TH17 cells in mice and humans (5–7). More recently, it has also 
been demonstrated that high salt diet inhibits the suppressive 
functions of Treg cells (8). Based on our findings in the NHS 
cohorts and in light of animal and human studies that have sup-
ported a role for sodium on regulation of immune tolerance and 
development of autoimmunity, we hypothesized that potassium, 
in contrast to sodium, may have an opposing effect on regula-
tory and effector T cells. To test our hypothesis, we activated the 
naïve CD4+ T cells in the presence of potassium and tested their 
proliferation. Potassium concentrations were selected based on 
its known physiologic concentrations in the gut lumen, mucosal 
cells, and extracellular fluids (37). As expected, potassium sup-
pressed the T cells proliferation and induced Foxp3 expression 
(Figures 1A,B). Since TGF-β1 induces the generation of Foxp3+ 
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Tregs cells, next we tested whether potassium can further 
enhance the induction of TGF-β-induced Foxp3+ Tregs cells. 
To do this, we activated the sorted naïve human T cells with 
TGF-β1 in the presence and absence of potassium. As previously 
suggested, TGF-β1 treatment induced the expression of Foxp3 
(~11%). Moreover, the addition of potassium further enhanced 
the generation of TGF-β-induced Foxp3+ Treg cells (from ~11% 
to ~31%) (Figure 1C). We further tested whether the enhancing 
effect of potassium on induction of Foxp3 expression is restricted 
to naïve CD4+ T cells. Addition of potassium also enhanced the 
generation of TGF-β1-induced Foxp3+ Treg cells (~ 21% to ~ 46%) 
(Figure 1C). Potassium at various concentrations also enhanced 
Foxp3 expression in sorted naïve and memory cells derived from 
healthy individuals cultured with TGF-β1 (Figures 1D,E). With 
10mM of KCl, the expression of Foxp3 was nearly doubled (~7% 
to ~12%), and further enhanced to nearly threefold with 40 mM 
KCl (from ~7% to ~20%) (Figure  1E). We observed a similar 
effect on TGF-β1-induced Foxp3 expression on sorted memory 
CD4+ T cells.
TGF-β1 is a common differentiation factor for the generation 
of TH17 and Foxp3+-induced regulatory T cells (iTregs) cells. 
Proinflammatory cytokines, IL-6, IL-1β, IL-21, and IL-23 sup-
press the generation of TGF-β1-induced Treg cells by inhibiting 
the expression of Foxp3, which in turn favor development of TH17 
cells. Since potassium enhanced the generation of Foxp3+ Tregs 
induced by TGF-β1, we tested whether potassium can suppress 
the inhibitory effect of TH17 cells inducing cytokines such as IL-6 
and IL-1β, and therefore reinforce the expression of Foxp3 in 
TH17 cells. The addition of potassium in TH17 culture condition 
overcame the inhibitory effect of IL-6/IL-1β on Foxp3+ Tregs and 
reinforced the expression of Foxp3 in TH17 cells (Figure  1F). 
We also evaluated whether high doses of potassium in these 
assays may induce T cells death. Sorted T cells were cultured in 
the presence or absence of 40  mM potassium and tested their 
viability. We did not find any difference in the viability of T cells 
cultured with or without potassium (Figure 1G). Taken together 
these results demonstrate that potassium, in contrast to sodium, 
enhances the generation of Foxp3+ Treg cells without affecting 
the cell viability.
Mechanism of Potassium-Mediated 
generation of Foxp3+ Tregs
We explored the potential mechanisms by which potassium 
enhanced expression of Foxp3 by evaluating its effect on Smad 
pathway. It is known that Smad2/3 pathway is critically essential 
for TGF-β1-mediated induction of Foxp3 while inhibition of 
Smad7 is crucial for generating and maintaining Treg phenotype 
(38–40). Smad2/Smad3 double deficient mice develop fatal 
inflammatory diseases with reduction in Foxp3 expression in 
CD4+ T cells while Smad2 deficiency make mice susceptible 
to DSS induced colitis (39). In addition, Smad7 appears to be 
over-expressed in purified mucosal T cells from CD patients 
and its inhibition restores TGF-β1 signaling by enhancing the 
functions of Smad3 (40). Interestingly, oral SMAD7 antisense 
oligonucleotide was recently successfully used for treatment of 
CD in randomized clinical trial (41).
Since potassium enhanced the function of TGF-β1 in induc-
ing the expression of Foxp3, we tested the effect of potassium 
on Smad2, Smad3, and Smad7 in human T cells by measuring 
its phosphorylation in TH17 cells. We found that potassium 
increased phosphorylation of Smad2 in TH17 cells (Figure 2A) 
and enhanced expression of total Smad2 in TH17 cells (Figure 2B). 
To further confirm this observation, we also tested the mRNA 
expression of Smad2 in TH17 cells. Potassium significantly 
increased the expression of Smad2 in TH17 cells (Figure  2C) 
and phosphorylation and expression of Smad3 (Figures 2D–F). 
Since the absence of Smad7 is required for the positive auto-
regulatory loop of TGF-β1 on regulatory T cells, we explored 
whether potassium also suppresses the expression of Smad7 in 
TH17 cells. Potassium significantly suppressed the expression of 
Smad7 in TH17 cells (Figure 2G), which may in turn reinforce the 
expression of Foxp3 and Treg cells phenotypes. Taken together, 
these observations imply that exposure of potassium to T cells 
increased the generation of Foxp3 by activating Smad2/3 and 
inhibiting Smad7 expression.
DiscUssiOn
In two large prospective cohorts of U.S. women, we show that 
dietary potassium, but not sodium, is inversely associated with 
risk of CD. Notably, we observed a significant interaction between 
dietary potassium and rs7657746 (IL21) in the TH17 pathway, 
supporting a biological mechanism that may mediate the effect 
of potassium on development of CD. IL-21 plays a key role in 
development of TH17 cells through STAT3, a transcription factor 
required for the differentiation of TH17 cells in vivo (42). IL-21 
and IL-23 induce the orphan nuclear receptor RORγ, which in 
synergy with STAT3 promotes IL-17 expression in CD4+ T cells, 
leading to induction of TH17 cells (42). In addition, IL-21 inhib-
its the generation of FoxP3+ Treg induced by TGF-β to induce 
TH17 cells. We corroborated our findings by showing in  vitro 
that potassium regulates Treg/TH17 balance through induction 
of Foxp3 expression in naïve and memory T cells as well as 
TH17 cells even in the presence of proinflammatory cytokines. 
This effect appeared to be mediated through increase in both 
phosphorylation and expression of Smad2 and Smad3 and sup-
pression of Smad7 expression.
In contrast to potassium, recent data have shown a proin-
flammatory role for sodium mediated by the induction and 
generation of pathogenic TH17 cells in human and mice (5, 6). 
Moreover, a high sodium diet enhances the susceptibility of tis-
sue inflammation in experimental autoimmune encephalomy-
elitis in animal models with augmented TH17 cell response (5). 
Interestingly, the proinflammatory effect of sodium appears to 
be further enhanced through marked reduction in Foxp3+ Tregs 
functions (8). TH17 cells and Tregs can be induced reciprocally, 
as TGF-β alone generates Tregs by inducing the expression of 
Foxp3 while addition of IL-6 together with TGF-β suppresses 
the expression of Foxp3 and generates IL-17-producing TH17 
cells (43). In contrast to the effect of sodium on TH17 cells and 
Tregs, our findings show that potassium not only enhances the 
induction of Foxp3 induced by TGF-β1 but also reinforces Foxp3 
expression in TH17 cells suggesting a possible anti-inflammatory 
FigUre 2 | Mechanism of extracellular potassium-mediated generation of Treg. (a–c) Naïve (CD4+ CD45RO−CD25−) CD4+ T cells were sorted from total 
PBMCs, cells were stimulated in vitro with anti-CD3 and anti-CD28 and polarized into TH17 cells with and without potassium (40mM). After 24 h of in vitro 
polarization, cells were analyzed by flow cytometry for the phosphorylated levels of Smad2 (B) and total levels of Smad2 protein (c). Cells were analyzed at 48 h for 
the expression of Smad2 mRNA by q-RT PCR (D), data are a cumulative representative plot of three individuals (n = 3), each dot represents one individual. 
*P < 0.05 (Student’s t-test). (e,F) Naïve (CD4+ CD45RO−CD25−) CD4+ T cells were sorted from total PBMCs. Cells were stimulated in vitro with anti-CD3 and 
anti-CD28 and polarized into TH17 cells with or without potassium (40mM). After 24 h of in vitro polarization, cells were analyzed by flow cytometry for the 
phosphorylation of Smad3 (e) and total levels of Smad2 protein (F) and mRNA expression was analyzed at 48 h for the Smad3 by q-RT PCR, data are a cumulative 
representative plot of three individuals (n = 3), each dot represents one individual, **P < 0.01 (Student’s t-test). (g) Naïve (CD4+ CD45RO−CD25−) CD4+ T cells were 
sorted from total PBMCs and in vitro stimulated with anti-CD3 and anti-CD28 with TH17 culture condition with or without potassium (40mM). After 48 h of activation, 
cells were analyzed by q-RT PCR of Smad7 mRNA. Representative plot of five individuals (n = 5), each dot represents one individual, *P < 0.05 (Student’s t-test).
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function of potassium via induction of Foxp3-mediated T cells 
tolerance.
Consistent with our observation that potassium may have 
anti-inflammatory effects on activated TH17 cells, Wen and col-
leagues recently demonstrated that potassium supplementation 
in healthy volunteers blocks IL-17 production by T cells previ-
ously treated with sodium. Interestingly, the effect appears to be 
mediated through the direct suppression of p38/MAPK-SGK1 
pathway (44). As SGK1 has a critical role in the induction of 
pathogenic TH17 cells in response to modest increase in sodium 
concentration (6), it appears that the balance between TH17 and 
Treg cells may in part be regulated by concentration of sodium 
and potassium. In support of this hypothesis, we also demonstrate 
that potassium supplementation, in contrast to sodium, inhibits 
the expression of SGK1 (Figure S1 in Supplementary Material). 
Similar to our findings, a recent study by Eil and colleagues also 
demonstrated the profound suppressive effect of potassium, 
released into the extracellular fluid as a result of necrosis in 
human tumors, on T cell effector function (45).
The plasticity of TH17 and Treg cells is well established as 
human Tregs, in a given proinflammatory environment can 
adopt TH17 phenotype and express IL-17 (46–48). Similarly, 
Foxp3-expressing human TH17 cells retain suppressive functions 
(47). Our data therefore suggest that potassium induces the 
TH17-Tregs plasticity by inducing Foxp3 in TH17 cells. Whether 
potassium-mediated induction of Foxp3 into TH17 cells leads 
these cells to develop a suppressive phenotype is the topic of 
future work. Lastly, IL-21 appears to play a key role in develop-
ment of TH17 cells through STAT3, a transcription factor required 
for the differentiation of TH17 cells in vivo (42). However, it is not 
clear whether our gene–environment interaction data suggest a 
specific role for IL-21 in potassium-mediated induction of Foxp3.
Our study has several notable strengths, including prospec-
tively collected and updated information on diet and other 
important life style factors, corroborative findings from gene–
environment interactions, and compelling correlative in  vitro 
functional studies. Taken together, these provide complementary 
lines of evidence that enhance the likelihood that the association 
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between dietary potassium and IBD is causal. We acknowledge 
limitations of our study, including measurement errors arising 
from use of FFQs to estimate dietary potassium and sodium 
and a limited sample size in our analyses of gene–environment 
interaction. Lastly, we acknowledge that potassium concentra-
tion is tightly regulated in the extracellular fluids (~5  mEq/L). 
However, its concentration in the gut lumen and the mucosal 
cells vary significantly (16–130 mEg/L), therefore, concentrations 
(2.5–40 mM) used in our in vitro experiments appear to be in 
physiologic range. In addition, similar concentrations were used 
in recent study evaluating the inhibitory effect of potassium on 
antitumor T cell response (45).
In conclusion, we show that dietary potassium is inversely 
associated with risk of CD with both in vitro and gene–environ-
ment interaction data suggesting a potential role for potassium in 
regulating immune tolerance through its effect on Tregs and TH17 
pathway. To our knowledge this is the first study demonstrating 
a potential interaction between dietary intake, genetic risk, and 
immune function on risk of developing CD. Further research to 
better elucidate the precise mechanisms by which dietary potas-
sium may modulate immune tolerance through regulating the 
TH17/Tregs balance is warranted. Finally, investigating a role for 
dietary potassium in modulating disease activity among patients 
with established CD and specific genotype should be a high 
priority.
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